Crypto lawyers question SEC Chair over claims of crypto being security

2023-2-27 11:41

Crypto lawyers have criticized the U.S. SEC Chair's comments. The SEC Chair claimed that every cryptocurrency except Bitcoin is a security subject to its jurisdiction. So far, SEC has either fiThe post Crypto lawyers question SEC Chair over claims of crypto being security appeared first on AMBCrypto.

Similar to Notcoin - Blum - Airdrops In 2024

origin »

Emerald Crypto (EMD) на Currencies.ru

$ 0 (+0.00%)
Объем 24H $0
Изменеия 24h: 0.00 %, 7d: 4.67 %
Cегодня L: $0 - H: $0
Капитализация $0 Rank 99999
Цена в час новости $ 0.0095806 (-100%)

crypto sec chair security lawyers being question

Источник: ambcrypto.com

crypto sec → Результатов: 126


SEC Commissioner says agency’s approach to crypto has been a “disaster for the whole industry”

SEC Commissioner Mark Uyeda said the agency hasn’t provided guidance on securities laws His comments come as Crypto.com sues the SEC for overreaching its regulatory authority over crypto after receiving a Wells notice A US Securities and Exchange Commission (SEC) commissioner has said that the agency’s approach to crypto has been a “disaster for the […] The post SEC Commissioner says agency’s approach to crypto has been a “disaster for the whole industry” appeared first on CoinJournal.

2024-10-11 13:20


Фото:

Coinbase sues SEC in ‘reverse UNO’ move on crypto transparency – reports

Coinbase has taken a bold step in its ongoing struggle with financial regulators. As Fox Business reported, the company has filed lawsuits against both the Securities and Exchange Commission (SEC) and the Federal Deposit Insurance Corporation (FDIC) in a Washington, DC district court, seeking access to internal documents related to crypto regulation.

2024-6-27 16:15


дальше еще 77 новостей →

Партнеры Currencies.ru

Аналог Notcoin - Blum - Играй и зарабатывай Монеты



Реклама на Currencies.ru

Самое свежее на Currencies.ru

Experts Back Cardano For 500% Gains or More

Cardano's ADA token has witnessed a significant surge over the past five weeks, climbing 300% to reach near two-year highs at $1.29 - but there's plenty more where that came from top analysts say.